CREATIVE MEDICAL TECHNOLOGY (CELZ) Stock Income Statement
NASDAQ:CELZ - Nasdaq - US22529Y4089 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.00K | 9.00K | 90.00K | 90.00K | 160.00K | |||
| Cost Of Goods | 4.40K | 3.60K | 30.00K | 50.00K | 50.00K | |||
| Gross Profit | 6.60K | 5.40K | 60.00K | 40.00K | 110.00K | |||
| Operating Expenses | 5.75M | 5.63M | 10.30M | 3.17M | 1.23M | |||
| Research and Development | 2.40M | 1.97M | 6.27M | 110.00K | N/A | |||
| Selling, General, and Administrative Expenses | 3.24M | 3.56M | 3.94M | 2.96M | 1.16M | |||
| Operating Income | -5.74M | -5.62M | -10.24M | -3.13M | -1.11M | |||
| Interest Income/Expense | 250.40K | 333.60K | 0.00 | 21.75M | -35.21M | |||
| Other Income/Expense | N/A | N/A | 100.00K | N/A | N/A | |||
| Non Recurring Items | N/A | N/A | 0.00 | 590.00K | 0.00 | |||
| Income Before Taxes | -5.49M | -5.29M | -10.14M | 19.21M | -36.33M | |||
| Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | N/A | |||
| Net Income | -5.49M | -5.29M | -10.14M | 19.21M | -36.33M | |||
| EBITDA | -5.63M | -5.53M | -10.15M | -3.04M | -1.04M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -3.71 | -3.76 | -9.30 | 60.03 | -605.50 | |||
| Non GAAP EPS | -3.71 | -3.69 | -9.80 | N/A | N/A | |||
| Statistics | ||||||||
| Gross Profit Margin | 60.00% | 60.00% | 66.67% | 44.44% | 68.75% | |||
| Profit Margin | -49940.91% | -58740.00% | -11266.67% | 21344.44% | -22706.25% | |||
| Operating Profit Margin | -52217.27% | -62445.56% | -11377.78% | -3477.78% | -693.75% | |||
All data in USD